Epigenomics Ag Stock Analysis

EPGNF Stock  USD 0.50  0.00  0.00%   
Epigenomics AG is overvalued with Real Value of 0.48 and Hype Value of 0.5. The main objective of Epigenomics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Epigenomics AG is worth, separate from its market price. There are two main types of Epigenomics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Epigenomics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Epigenomics' stock to identify patterns and trends that may indicate its future price movements.
The Epigenomics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Epigenomics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Epigenomics Pink Sheet trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Epigenomics' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epigenomics AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Epigenomics Pink Sheet Analysis Notes

About 35.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.39. Some equities with similar Price to Book (P/B) outperform the market in the long run. Epigenomics AG recorded a loss per share of 0.3. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 27th of December 2022. Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany. Epigenomics operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 36 people.The quote for Epigenomics AG is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Epigenomics AG call Gregory Hamilton at 49 30 243 450 or check out https://www.epigenomics.com.

Epigenomics AG Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Epigenomics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Epigenomics AG or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Epigenomics AG is way too risky over 90 days horizon
Epigenomics AG has some characteristics of a very speculative penny stock
Epigenomics AG appears to be risky and price may revert if volatility continues
The company reported the revenue of 6.2 M. Net Loss for the year was (2.43 M) with profit before overhead, payroll, taxes, and interest of 6.07 M.
Epigenomics AG has accumulated about 15.77 M in cash with (4.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 35.0% of the company shares are held by company insiders

Epigenomics Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Epigenomics's market, we take the total number of its shares issued and multiply it by Epigenomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 28th of March, Epigenomics shows the Mean Deviation of 11.97, standard deviation of 50.36, and Variance of 2536.13. Epigenomics AG technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate eleven technical drivers for Epigenomics AG, which can be compared to its rivals. Please confirm Epigenomics AG coefficient of variation and treynor ratio to decide if Epigenomics AG is priced favorably, providing market reflects its regular price of 0.5 per share. As Epigenomics AG is a penny stock we also recommend to verify its information ratio numbers.

Epigenomics AG Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Epigenomics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Epigenomics AG. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Epigenomics Predictive Daily Indicators

Epigenomics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Epigenomics pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Epigenomics Forecast Models

Epigenomics' time-series forecasting models are one of many Epigenomics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Epigenomics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Epigenomics Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Epigenomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Epigenomics shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Epigenomics. By using and applying Epigenomics Pink Sheet analysis, traders can create a robust methodology for identifying Epigenomics entry and exit points for their positions.
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany. Epigenomics operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 36 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Epigenomics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epigenomics AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Epigenomics Pink Sheet analysis

When running Epigenomics' price analysis, check to measure Epigenomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epigenomics is operating at the current time. Most of Epigenomics' value examination focuses on studying past and present price action to predict the probability of Epigenomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epigenomics' price. Additionally, you may evaluate how the addition of Epigenomics to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamental Analysis
View fundamental data based on most recent published financial statements
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Stocks Directory
Find actively traded stocks across global markets
Please note, there is a significant difference between Epigenomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Epigenomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Epigenomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.